Adeno-associated virus serotypes: vector toolkit for human gene therapy (Q33249130)

24 July 2017

1 reference

title

Adeno-associated virus serotypes: vector toolkit for human gene therapy (English)

1 reference

24 July 2017

0 references

0 references

Zhijian Wu

1

1 reference

PubMed ID

16824801

24 July 2017

Aravind Asokan

series ordinal

2

1 reference

PubMed ID

16824801

24 July 2017

R Jude Samulski

series ordinal

3

1 reference

24 July 2017

7 July 2006

1 reference

24 July 2017

1 reference

24 July 2017

14

1 reference

24 July 2017

316-327

1 reference

24 July 2017

3

1 reference

Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus vectors in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Delivery of MDR1 small interfering RNA by self-complementary recombinant adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

AAV hybrid serotypes: improved vectors for gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Characterization of the DNA of a defective human parvovirus isolated from a genital site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Clades of Adeno-associated viruses are widely disseminated in human tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

New recombinant serotypes of AAV vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Cloning and characterization of a bovine adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Coinfection of a bearded dragon, Pogona vitticeps, with adenovirus- and dependovirus-like viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Isolation of an adenovirus and an adeno-associated virus from goat kids with enteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Novel tools for production and purification of recombinant adenoassociated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Insect cells as a factory to produce adeno-associated virus type 2 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Scalable generation of high-titer recombinant adeno-associated virus type 5 in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Serum-free production and column purification of adeno-associated virus type 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Identification of a heparin-binding motif on adeno-associated virus type 2 capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Identification of PDGFR as a receptor for AAV-5 transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus types 5 and 6 use distinct receptors for cell entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Intracellular trafficking of adeno-associated viral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

AAV transcytosis through barrier epithelia and endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Infection of purified nuclei by adeno-associated virus 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Real-time single-molecule imaging of the infection pathway of an adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Structure of adeno-associated virus type 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Structure of adeno-associated virus serotype 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Generation and characterization of chimeric recombinant AAV vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Insertional mutagenesis of AAV2 capsid and the production of recombinant virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Altering AAV tropism with mosaic viral capsids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Characterization of tissue tropism determinants of adeno-associated virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

DNA shuffling of a family of genes from diverse species accelerates directed evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Laboratory-directed protein evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Breeding of retroviruses by DNA shuffling for improved stability and processing yields

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Molecular breeding of viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Directed evolution of adeno-associated virus yields enhanced gene delivery vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.05.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2006.05.009

1 reference

24 July 2017

1 reference

PubMed ID

16824801